These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3295765)

  • 1. Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolism.
    Guttendorf RJ; Britto M; Blouin RA; Foster TS; John W; Pittman KA; Wedlund PJ
    Br J Clin Pharmacol; 1990 Apr; 29(4):373-80. PubMed ID: 2328190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in drug metabolism: importance of genetic constitution.
    Schellens JH; Breimer DD
    Pharm Weekbl Sci; 1987 Apr; 9(2):85-90. PubMed ID: 3295765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphic drug oxidation in humans.
    Eichelbaum M
    Fed Proc; 1984 May; 43(8):2298-302. PubMed ID: 6714436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450: genetic polymorphism and drug interactions.
    Belpaire FM; Bogaert MG
    Acta Clin Belg; 1996; 51(4):254-60. PubMed ID: 8858891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical consequences of polymorphic drug oxidation.
    Alván G
    Fundam Clin Pharmacol; 1991; 5(3):209-28. PubMed ID: 1937350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of genetic polymorphisms of drug metabolism.
    Meyer UA; Zanger UM
    Annu Rev Pharmacol Toxicol; 1997; 37():269-96. PubMed ID: 9131254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic control of drug oxidation in the liver.
    Dayer P; Balant L; Fabre J
    Int J Clin Pharmacol Res; 1983; 3(6):421-5. PubMed ID: 6147316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic control of isoniazid metabolism in man.
    EVANS DA; MANLEY KA; McKUSICK VA
    Br Med J; 1960 Aug; 2(5197):485-91. PubMed ID: 13820968
    [No Abstract]   [Full Text] [Related]  

  • 9. A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.
    Evans DA; Mahgoub A; Sloan TP; Idle JR; Smith RL
    J Med Genet; 1980 Apr; 17(2):102-5. PubMed ID: 7381862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine.
    Bertilsson L; Dengler HJ; Eichelbaum M; Schulz HU
    Eur J Clin Pharmacol; 1980 Feb; 17(2):153-5. PubMed ID: 7371707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inheritance of phenytoin hypometabolism: a kinetic study of one family.
    Vasko MR; Bell RD; Daly DD; Pippenger CE
    Clin Pharmacol Ther; 1980 Jan; 27(1):96-103. PubMed ID: 7351122
    [No Abstract]   [Full Text] [Related]  

  • 12. Defective oxidation of drugs: pharmacokinetic and therapeutic implications.
    Eichelbaum M
    Clin Pharmacokinet; 1982; 7(1):1-22. PubMed ID: 7042170
    [No Abstract]   [Full Text] [Related]  

  • 13. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.
    Holford NH; Sheiner LB
    Clin Pharmacokinet; 1981; 6(6):429-53. PubMed ID: 7032803
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.